SBIR Phase I: Development of 18F-radiotracer kits for detection of biomarkers by Positron — NSF Award to THERACEA PHARMA LC (AZ, $
The broader impact and commercial potential of this Small Business Innovation Research (SBIR) Phase I project extend to several key areas. Firstly, it aims to enhance the quality of healthcare and improve the health outcomes of the American public by offering cutting-edge diagnostic tools for the detection and assessme
| Award title | SBIR Phase I: Development of 18F-radiotracer kits for detection of biomarkers by Positron |
|---|---|
| Award ID | 2423679 |
| Awardee | THERACEA PHARMA LC |
| City | TUCSON |
| State | AZ |
| Amount obligated | $295,000 |
| Principal investigator | Iman Daryaei |
| Program | SBIR Outreach & Tech. Assist, SBIR Phase I |
| Start date | 09/01/2024 |
| Abstract | The broader impact and commercial potential of this Small Business Innovation Research (SBIR) Phase I project extend to several key areas. Firstly, it aims to enhance the quality of healthcare and improve the health outcomes of the American public by offering cutting-edge diagnostic tools for the detection and assessment of various diseases. These advanced diagnostics will provide clinicians with precise and reliable information, thereby improving disease management and patient care. Secondly, t |
| Source | NSF Awards |
$799/mo
Try NSFGrants →